arsenic trioxide and Uterine Cervical Neoplasms

Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Cervical Neoplasms

Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Female; Humans; Meta-Analysis as Topic; Platinum Compounds; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Delivery Systems; Female; Humans; Liposomes; Oxides; Papillomavirus Infections; Particle Size; Static Electricity; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Female; Folic Acid; HeLa Cells; Humans; Liposomes; Papillomaviridae; Polyethylene Glycols; Uterine Cervical Neoplasms

Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Proliferation; Chemokine CXCL12; Down-Regulation; Female; HeLa Cells; Humans; Lung Neoplasms; Mice; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Oxides; Protein Phosphatase 2; Receptors, CXCR4; RNA, Messenger; Signal Transduction; Transcription, Genetic; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Female; HeLa Cells; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Oxides; Papillomavirus E7 Proteins; Papillomavirus Infections; Repressor Proteins; Retinoblastoma Protein; Transcription Factor AP-1; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Glutathione; HeLa Cells; Humans; Humic Substances; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred NOD; Mice, SCID; Mitosis; Oxides; Reactive Oxygen Species; Transplantation, Heterologous; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A

Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Caspases; Cell Nucleus; Combined Modality Therapy; Cytosol; Female; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Membrane Potential, Mitochondrial; Mitochondria; Oxides; Phosphorylation; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation, Ionizing; Reactive Oxygen Species; Signal Transduction; Uterine Cervical Neoplasms

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cisplatin; Drug Interactions; Drug Synergism; Female; Fluorouracil; Head and Neck Neoplasms; Humans; In Vitro Techniques; Inhibitory Concentration 50; Oxides; Paclitaxel; Poly(ADP-ribose) Polymerases; Stomach Neoplasms; Tubulin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Female; HeLa Cells; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Stathmin; Survival Analysis; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; DNA Primers; Female; HeLa Cells; Human papillomavirus 16; Humans; Oxides; Papillomavirus Infections; Polymerase Chain Reaction; RNA, Messenger; Uterine Cervical Neoplasms; YY1 Transcription Factor

Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Female; Flow Cytometry; Gene Silencing; Growth Inhibitors; Heat-Shock Proteins; Humans; Intracellular Signaling Peptides and Proteins; Membrane Transport Proteins; Microscopy, Fluorescence; Oxides; p38 Mitogen-Activated Protein Kinases; Plasmids; Polymerization; RNA, Small Interfering; Signal Transduction; Transfection; Tubulin; Tubulin Modulators; Up-Regulation; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Oncogene Proteins, Viral; Oxides; Papillomavirus Infections; Repressor Proteins; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Mice; Neoplasm Proteins; Neoplasms, Experimental; Oxides; Photochemotherapy; Uterine Cervical Neoplasms

Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; Humans; Mice; Oxides; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Neoplasm Invasiveness; Oncogene Proteins, Viral; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Transcription Factor AP-1; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Northern; Cell Cycle; Cell Division; Cell Line, Tumor; DNA; DNA Fragmentation; DNA Repair; DNA, Complementary; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Oxides; RNA; Time Factors; Up-Regulation; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; fas Receptor; Female; Gene Expression Regulation, Neoplastic; Humans; NF-kappa B; Oxides; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured; Up-Regulation; Uterine Cervical Neoplasms

Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Caspase 9; Cell Line, Tumor; Female; Humans; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Microtubules; Mitochondria; Oxides; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

Topics: Animals; Arsenic Trioxide; Arsenicals; beta Catenin; Cadherins; Caveolin 1; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Growth Inhibitors; HeLa Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Oxides; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Blotting, Western; Enzyme Activation; Female; HeLa Cells; Humans; MAP Kinase Kinase 4; Membrane Potential, Mitochondrial; Mitochondria; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Transfection; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Female; Humans; Leukemia; Lymphoma; Multiple Myeloma; Neoplasms; Oxides; Urogenital Neoplasms; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Size; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Ovarian Neoplasms; Oxides; Sulfides; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Cell Cycle; Cell Survival; DNA, Neoplasm; Female; Humans; Oxides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; HeLa Cells; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Radiation-Sensitizing Agents; Treatment Outcome; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays